European In-Vitro Diagnostic Testing Services Market Trends and Forecasts Report 2016-2019 - Research and Markets

DUBLIN, May 27, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "In Vitro Diagnostic Testing Services Market Trends and Forecasts 2016-2019 - Europe" report to their offering.

A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations.

Trends like:

- changing demographics

- emerging economies and global prosperity

- biotechnology advances in genetics

- pathogen evolution

- climate change

- globalization

- automation

Exciting technical developments especially in the area of molecular diagnostics and pharmacogenomics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.

Based on extensive primary and secondary research the testing volume data is broken down into price and volumes allowing researchers and investors to quickly create informed and reasonable forecasts of demand. Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth.

The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

Key Topics Covered:

1. Introduction and Market Definition

2. Market Overview

2.1 Market Participants

2.2 Market Segments

2.3 Industry Structure

2.4 Profiles of Key Companies

2.5 National and Regional Diversity

3. Market Trends

3.1 Factors Driving Growth

3.2 Factors Limiting Growth

3.3 Automation

3.4 Environment and Evolution

3.5 Diagnostic Technology Development

4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments

5. Country Markets - Europe

6. The Future of the Clinical Laboratory

Companies Mentioned

- 14M Genomics

- 23Andme

- Abbott Laboratories

- Abcam

- Accelerate Diagnostics

- Achieving Dx

- Acibadem Labmed Laboratory

- Acm Medical Laboratory

- Act Genomics

- Adaptive Biotechnologies

- Adicon Clinical Laboratories, Inc.

- Aegis Sciences

- Agena Bioscience

- Alere Inc

- Arup Laboratories, Inc.

- Ascend Clinical, Llc

- Astrazeneca

- Atossa Genetics

- Aurora Diagnostics, Llc

- Avant-Amarantus-Theranostics

- Baylor College of Medicin

- Biofortuna

- Biomerieux

- Biomnis (France)

- Bio-Reference Laboratories, Inc.

- Bioscientia Institut Fuer Medizinische Diagnostik Gmbh

- Bp Lab

- Canon Us Life Sciences

- Caprion

- Cardiodx

For more information visit http://www.researchandmarkets.com/research/k98k88/in_vitro

Media Contact:

Research and Markets

Laura Wood, Senior Manager

[e-mail]

For E.S.T Office Hours Call [phone]

For U.S./CAN Toll Free Call [phone]

For GMT Office Hours Call [phone]

U.S. Fax: [phone]

Fax (outside U.S.): [phone]